CV8102
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CV8102, covering 2018-06-06 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients [Phase 1, Phase 2]